Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Antisense & Nucleic Acid Drug Development|March 25, 1998
Ex vivo effects associated with the expression of a bcr-abl-specific ribozyme in a CML cell lineL A Wright, S Milliken, J C Biggs, et al.
Australian and New Zealand Journal of Medicine|February 1, 1996
Five year leukaemia-free survival of 72% and 77% for early stage acute and chronic myeloid leukaemia treated by HLA-identical sibling bone marrow transplantationK Atkinson, K Downs, A Dodds, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Sequential moderate-dose methotrexate and 5-fluorouracil in advanced gastric adenocarcinomaR Dickinson, P Presgrave, J Levi, et al.
Experimental Hematology|August 1, 1995
Improved specificity of ribozyme-mediated cleavage of bcr-abl mRNAP Kearney, L A Wright, S Milliken, et al.
Experimental Hematology|December 1, 1993
Ribozyme-mediated cleavage of the bcr/abl transcript expressed in chronic myeloid leukemiaL Wright, S B Wilson, S Milliken, et al.
Australian and New Zealand Journal of Medicine|June 1, 1986
The intraventricular reservoir in the treatment of neurological disease secondary to hematological malignancy: an eight year experienceG A Young, S Milliken, J Jurd, et al.
Bone Marrow Transplantation|July 6, 2004
A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantationJ Moore, D Ma, R Will, et al.
BMJ (Clinical Research Ed.)|December 16, 1989
Consequences and treatment of ovarian failure after total body irradiation for leukaemiaM P Cust, M I Whitehead, R Powles, et al.
Journal of Molecular and Cellular Cardiology|December 8, 2022
Distinct effects of intracellular vs. extracellular acidic pH on the cardiac metabolome during ischemia and reperfusionAlexander S Milliken, Jessica H Ciesla, Sergiy M Nadtochiy, et al.
Bone Marrow Transplantation|May 13, 1998
A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989K Atkinson, I Nivison-Smith, A Dodds, et al.
Pageof 6